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Abstract: Electrical stimulation is an attractive approach to tune on-demand drug release in the 11 
body as it relies on simple setups and requires typically 1 V or less. Although many studies have 12 
been focused on the development of potential smart materials for electrically controlled drug 13 
release as well on the exploration of different delivery mechanisms, progress in the field is being 14 
slow because the response of cells exposed to external electrical stimulus is frequently omitted from 15 
such investigations. In this work we monitor the behavior of prostate and breast cancer cells (PC-3 16 
and MCF7, respectively) exposed to electroactive platforms loaded with curcumin, a hydrophobic 17 
anticancer drug. These consist in conducting polymer nanoparticles, which release drug molecules 18 
by altering their interactions with polymer, and electrospun polyester microfibers that contain 19 
electroactive nanoparticles able to alter the porosity of the matrix through an electro-mechanical 20 
actuation mechanism. The response of the cells against different operating conditions has been 21 
examined considering their viability, metabolism, spreading and shape. Results have allowed us to 22 
differentiate the damage induced in the cell by the electrical stimulation from other effects, as for 23 
example the anticancer activity of curcumin and/or the presence of curcumin-loaded nanoparticles 24 
or fibers, demonstrating that these kinds of platforms can be effective when the dosage of the drug 25 
occurs under restricted conditions.  26 
 27 
Keywords: Anticancer activity; Cell damage; Conducting polymer; Drug delivery; 28 
Electrostimulation; Nanoparticles; Polycaprolactone; Polyesters 29 
 30 
1. Introduction 31 
On demand local delivery of drug molecules to target tissues provides a means for effective 32 
drug dosing, fulfilling requirements for a variety of therapeutic applications while reducing the 33 
adverse effects of systemic drug delivery [1-4]. Recent advances have facilitated the use of various 34 
cues, such as UV- and visible-wavelength light, near-infrared (NIR) radiation, magnetic field, 35 
ultrasound and electrical stimulation to trigger drug release in vivo from implanted smart materials 36 
[1,4,5]. Among them, pulsatile electrically stimulated drug delivery devices have drawn attention 37 
not only because they allow repeatable and reliable drug release flux for clinical needs but also 38 
because of their simplicity and versatility. Thus, various types of electrically modulated devices for 39 
drug release, such as hydrogel [6-9], nanoparticles [10-13], membranes [14,15] and fibers [16-19] have 40 
been reported in literature. Besides, electrical stimulation has also been employed in the clinics for its 41 
potential beneficial effects to revive damaged tissues in the neuromuscular system, reduce the 42 
progression of diseases related to the bones such as osteoarthritis and osteonecrosis [20] to reduce 43 
pain [21] or to favorably treat Parkinson’s diseases [22]  44 
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Conducting polymers (CPs), which exhibit characteristics similar to those encountered in 45 
metals (i.e. good electrical, magnetic and optical properties) and the outstanding properties of 46 
conventional polymers (i.e. flexibility in processing, lightness of weight, and easiness in synthesis), 47 
are frequently the main component of electrically driven drug delivery systems. Thus, the excellent 48 
redox properties of CP matrices promote the uptake (oxidation) and the expulsion of (reduction) of 49 
charged drugs, the alteration of the electrostatic forces to facilitate the load or release of charged 50 
drugs being typically regulated by applying an external electric field. Besides, the actuation behavior 51 
(i.e. expansion and contraction) of CPs can be considered as another important and effective driving 52 
force in the drug delivery process [23,24]. Thus, the actuation experienced by CPs upon oxidation 53 
and reduction processes alters the porosity of the polymer matrix, regulating the release of drug 54 
molecules, especially of neutral ones. Typically electrostatic and actuation driving forces coexist to a 55 
greater or lesser extent depending on the characteristics of the drug and the CP matrix. 56 
Investigations in electrically stimulated polymer devices have been mainly focused in achieve 57 
controlled triggered drug delivery and in ascertain the mechanism involved in this process by 58 
weighting the electrostatic interactions and actuating properties as driving forces [6-19]. In a very 59 
recent review, the different mechanisms involved in the release of drugs upon electrical stimuli have 60 
been systematically and extensively discussed [25]. Thus, the mechanism depends not only on the 61 
redox state of the electrically active material (i.e. they can incorporate or release anionic or cationic 62 
molecules on-demand) but also on the format of the carrier (e.g. films, particles and fibers). 63 
However, electrical stimulation also affects the cell growth and geometry, which is usually not taken 64 
into account. It is well-known that at the cellular level, electrical stimulation can contribute to cell 65 
proliferation [26], migration (electrotaxis) [27], differentiation [28], endocytosis [29] and membrane 66 
permeabilization [30]. Particularly, at the intracellular level changes are produced in the Ca2+ entry 67 
modulation, in the integrin conformation, induction of plasma membrane depolarization, 68 
redistribution of the transmembrane proteins and reorganization of cytoskeletal structure. However, 69 
in this work, we investigate the influence of electrically stimulated drug delivery on cells viability 70 
and geometry (i.e. cell shape and area) using two different polymeric devices that were successfully 71 
used to electrically stimulate the release of curcumin (CUR) [12,16]. The latter is a neutral drug 72 
(Scheme 1) with a wide spectrum of medical properties ranging from anti-bacterial, anti-viral, 73 
anti-protozoal, anti-fungal, and anti-inflammatory activities to anti-cancer effects [31-33]. The two 74 
studied devices are the following:  75 
(1) Poly(3,4-ethylenedioxythiophene) nanoparticles (PEDOT-NPs) loaded with CUR, hereafter 76 
denoted PEDOT-NPs/CUR [12]. In this case, the delivery of CUR was regulated by controlling the 77 
strength of PEDOT···CUR specific interactions that became weaker when a reductive potential was 78 
applied to the loaded PEDOT-NPs. For example, the release measured after 3 min at −0.50 V, −1.0 79 
and −1.25 V was determined to be 9.9%, 30.4% and 38.4%, respectively. According to these 80 
experimental observations [12], the proposed mechanism was described as follows: 81 
(PEDOT+·DBSA–)···nCUR + e–  (PEDOT(-)+·(-)DBSA–)···mCUR + DBSA– + (n-m)CUR 82 
where nCUR corresponds to the drug molecules hydrogen bonded to the oxidized PEDOT-NPs, 83 
mCUR corresponds to the drug molecules that remain hydrogen bonded to the PEDOT-NPs after 84 
inject  electrons into the system applying an external voltage, and + and (-)+ are the oxidation 85 
states of oxidized and reduced PEDOT, respectively (i.e. when PEDOT is completely reduced, =, 86 
the charge of the conducting polymer is zero). The electro-regulated release of CUR was found to 87 
grow logarithmically with time. For example, when a reduction potential of −1.25 V was applied for 88 
a time t, the amount of released CUR increased from 7.1% for t= 30 s to 60.2% for t= 9 min [12]. 89 
(2) Electrospun poly(-caprolactone) (PCL) microfibers loaded with both PEDOT-NPs and 90 
CUR, hereafter after denoted PCL/PEDOT-NPs/CUR fibers [16]. In this case, PEDOT-NPs, which 91 
were mainly located inside the PCL microfibers, behaved as electro-actuators upon application of 92 
well-defined potential pulses, increasing their diameter by 17% and migrating from inside the PCL 93 
matrix to the surface of the microfibers. This electro-mechanical actuation behavior affected the 94 
structure of the PCL matrix and promoted the release of curcumin, the latter increasing with the 95 
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number of pulses [16]. For example, the release of CUR increased from 8% to 30% when the number 96 
of square potential pulses of 1 V for 60 s grew from 1 to 5 (separated for 5 s).” 97 
 98 
Scheme 1. Structure of CUR 99 
Considering that the biocompatibility of both PEDOT [34] and PCL [35] is well-known and that 100 
the mechanisms for the release of CUR from PEDOT-NPs/CUR and PCL/PEDOT-NPs/CUR were 101 
demonstrated, in this study we provide a new perspective that exclusively analyzes how the 102 
operating conditions used for application and regulation of pulsatile electrical stimulation affect the 103 
surrounding cells. For this purpose a dual study comparing two different conditions, without and 104 
with electrical stimulation, has been conducted. It is worth noting that, although in some studies the 105 
impact of the electric potential on some aspects of cells health have been reported [25], to the best of 106 
our knowledge no systematic study has been previously conducted. Moreover, this is especially 107 
notorious for the release of CUR.  108 
2. Materials and Methods  109 
2.1. PEDOT-NPs and PEDOT-NPs/CUR 110 
The synthesis of the PEDOT-NPs was conducted by emulsion polymerization in water at 40 ºC 111 
using 3,4-ethylenedioxythiophene (EDOT) monomer, sodium dodecylbenzene sulfonate (DBSA) as 112 
stabilizer and doping agent simultaneously, and ammonium persulfate (APS) as oxidizing agent. 113 
For PEDOT-NPs/CUR, the drug was loaded in situ during the same polymerization using a 10 114 
mg/mL CUR solution in ethanol.  115 
In brief, 0.0163 g of DBSA was added to tub filled with 4.5 mL of milli-Q water and the solution 116 
was stirred for 1 h at 750 rpm at room temperature. Then, 23.6 mg of EDOT monomer alone 117 
(PEDOT-NPs) or with 0.5 mL of the CUR solution in ethanol (PEDOT-NPs/CUR) were added. Again, 118 
the resulting solution was stirred for 1 h at 750 rpm at room temperature. Finally, 91.2 mg of APS 119 
dissolved in 0.5 mL of milli-Q water was added to the mixture. The reaction was maintained in 120 
agitation at 40 ºC overnight protected from light with aluminium foil. No sedimentation was 121 
observed after the reaction, indicating a good colloidal stability. Side products and unreacted 122 
chemicals were eliminated by a sequence of 3 centrifugations at 11000 rpm for 40 min at 4 ºC. The 123 
resulting supernatants were decanted and the pellet was re-dispersed in deionized water by using a 124 
vortex and a sonic bath (15 min at room temperature). Due to its hydrophobicity, CUR remained into 125 
the cores of the surfactant micelles rather than interacting with the medium. The drug loading ratio, 126 
expressed as mass of encapsulated drug with respect to the total mass, was 5.91.6%. 127 
Cyclic voltammetry (CV) studies were conducted with an Autolab PGSTAT302N galvanostat 128 
equipped with the ECD module (Ecochimie, The Netherlands). Measurements were performed on 129 
10 µL of 10 mg/mL NPs solution dried on a glassy carbon electrodes (GCE) of diameter = 2 mm. All 130 
electrochemical assays were performed using a three-electrode one compartment cell under a 131 
nitrogen atmosphere and at room temperature. The cell was filled with 10 mL of phosphate saline 132 
buffer (PBS) solution (pH 7.4) as a supporting electrolyte. Covered or bare GCE was used as the 133 
working electrode, platinum as the counter electrode, while an Ag|AgCl electrode containing KCl 134 
saturated aqueous solution was the reference electrode (offset potential versus the standard 135 
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hydrogen electrode, E° = 0.222 V at 25 °C). Oxidation-reduction cycles were registered within the 136 
potential range of −0.4 to +0.8 V at 100 mV/s scan rate. 137 
2.2. PCL and PCL/PEDOT-NPs/CUR fibers 138 
A mixture of PCL, PEDOT-NPs and CUR was prepared as follows for electrospinning: PCL (5.5 139 
g) was dissolved in 32 mL of a mixture of chloroform and acetone 2:1 (v/v). The solution was kept in 140 
37 ºC for 24 h under stirring at 100 rpm. PEDOT-NPs (10 mg/mL) and CUR (1.04 mg/mL) were and 141 
dispersed and dissolved, respectively, in 0.5 mL of ethanol. Finally, 0.2 mL of PEDOT-NPs and CUR 142 
solutions were mixed with 1.8 mL of PCL solution and loaded in a 5 mL plastic syringe for delivery 143 
through an 18G  1.1/2’’ needle at a mass-flow rate of 10 mL/h using a infusion pump. The content of 144 
PCL, PEDOT-NPs and CUR in the optimized electrospinning mixture was 15.45% (w/v) of PCL, 0.6 145 
wt% of PEDOT NPs and 0.06 wt% CUR. As a control, fibers of pure PCL were produced using a 146 
17.18% (w/v) concentration of polymer in 2:1 chloroform:acetone.  147 
The choice of the processing conditions (i.e. distance between the syringe tip and the collector, 148 
voltage and the flow rate) were selected on the basis of previous experiments devoted to optimize 149 
the morphology of the electrospun microfibers [16]. Thus, the formation of droplets and electrospun 150 
beads was completely avoided when microfibers were obtained by applying a voltage was 15 kV 151 
and using a needle tip-collector distance of 15 cm. 152 
2.3 Scanning electron microscopy (SEM)  153 
Micrographs were obtained using a Focused Ion Beam Zeiss Neon 40 scanning electron 154 
microscope operating at 10 kV. Samples were mounted on a double-side adhesive carbon disc and 155 
sputter-coated with a thin layer of carbon to prevent sample charging problems. The effective 156 
diameter of the nanoparticles and electrospun microfibers was determined from the SEM images 157 
using the software SmartTIFF (v1.0.1.2.). In order to visualize cells, before the carbon coating, 158 
samples with cells were fixed in a 2.5% formaldehyde PBS solution (pH = 7.2) overnight at 4 °C. 159 
Then, they were dehydrated by washing in an alcohol battery (30°; 50°; 70°; 90°; 95°; and 100°) at 4 °C 160 
for 15 min per wash. Finally, samples were air-dried and sputter-coated with carbon.  161 
2.4. 3D Cell culture and cell morphology by transmission electron microscopy (TEM) and confocal microscopy  162 
PC-3 (human prostate cancer cell line) and MCF7 (human breast cancer cell line) cells, which are 163 
frequently used in cancer research and drug development, were used for experiments. Both PC-3 164 
and MCF7 cell lines (were obtained from ECACC (European Collection of Cell Culture, UK). The 165 
previously described CUR delivery systems as well as their corresponding controls (i.e. PEDOT-NPs 166 
and PCL microfibers) were sterilized with an UV lamp for 30 min at both sides and attached with 167 
non-toxic silicon to the flat bottom of the wells in a 24-well/plate. Cells were seeded at a density of 168 
40000 cells/mL in Advanced Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 5% 169 
fetal bovine serum, 1% penicillin/streptomycin and 4 mM L-glutamine, and incubated overnight at 170 
37 °C and 5% of CO2. The next day, cells were washed gently with PBS and adhesion was evaluated 171 
by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-nyltetra-zolium] which was performed according to 172 
manufacturer instructions. Assays with n= 3 were repeated two times independently. The 173 
2,2’-azino-bis 3-ethylbenzthiazoline-6-sulfonic acid (ABTS) method was to measure the radical 174 
scavenging activity. 175 
The morphology of the cells incubated with the PEDOT-NPs was observed by TEM. Images 176 
were obtained with a Philips TECNAI 10 electron microscope operating at 100 kV. Bright field 177 
micrographs were taken with a SIS MegaView II digital camera). 5  105 cells/mL were cultured for 178 
24 h in sterile a T-25 flask, and PEDOT NPs (25 µg/mL) were added for another 24 h. After 179 
incubation, cells were washed with 0.1 M phosphate buffered saline solution (PBS), trypsinized with 180 
0.25 % Trypsin-EDTA (Gibco, USA), counted and 1 million cells collected in an Eppendorf. Then, 181 
they were prefixed with a modified Karnovsky’s fixative (mixed with 2% paraformaldehyde and 2% 182 
glutaraldehyde in 0.05 M PBS buffer) at 4 ºC for 2 h. After being washed three times with 0.1 M PBS, 183 
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cells were post-fixed with 1% osmium tetraoxide at 4 ºC for 2 h, washed 3 times with milli-Q water 184 
and stained with 0.5% uranyl acetate at 4 ºC overnight protected from light. Later on, dehydration 185 
was conducted through a graded series of 30, 50, 70, 80, 90, and 100% ethanol (15 min each) and then 186 
slowly embedded within the resin by a series of 2:1, 1:1 and 0:1 of propylene oxide : spurr’s resin (30 187 
min each). Resin blocks were cured at 65 ºC for 2 days and sectioned by ultramicrotomy. Before 188 
analyses the sections were stained with 2% uranyl acetate and Raynolds’ lead citrate. 189 
Confocal microscopy imaging was performed using an Axio Observer Z1 fluorescence 190 
microscope (Carl Zeiss) confocal laser scanning microscope with a 10x and 40x objectives. 191 
Morphology studies were performed with ImageJ software. Cells were fixed and stained for nucleus 192 
and F-actin on day 1. Particularly, after 24 h, cells were washed with PBS and fixed with 2.5 % 193 
paraformaldehyde in PBS for 40 min at room temperature. Later on, samples were washed 3 times 5 194 
min each with PBS  and permeabilized with 0.05% (w/v) triton X-100 in PBS for 20 min under 195 
agitation. After this, unspecific sites were blocked with a solution containing 1% bovine serum 196 
albumin, 22.52 mg/mL glycine and 0.1% Tween-20  in PBS for 30 min. F-actin filaments were stained 197 
with phalloidin atto-488 (Stock solution 10 nmol/500 uL methanol) used with a 1/50 dilution in PBS 198 
for 60 min at room temperature under agitation. Again samples were washed 3 times 5 min each 199 
with PBS. Finally, cell nucleus was stained with bis-Benzimide H33258 (Stock solution 2 mM) 200 
employed at 1/100 dilution in PBS during 30 min under soft constant agitation and mounted on the 201 
glass slides. Samples were protected from light and kept at 4 ºC before use.  202 
Each data point corresponds to the average of three samples and the error bars refer to the 203 
respective standard deviation. Greek letter on the column indicates a significant difference (p < 0.05) 204 
when 1 way ANOVA and Turkey’s multiple comparison tests have been applied. 205 
3. Results and discussion 206 
It is often challenging to apply electrical stimuli onto monolayer cell cultures. Herein, cells have 207 
been seeded onto the anode surface and, initially, our efforts have been devoted to identify the 208 
optimal potential difference for therapies based on the controlled release of drugs with the intention 209 
of not damaging healthy tissues. Since CUR presents an anticancer activity, all the assays have been 210 
conducted using prostate and breast cancer cell lines (PC-3 and MCF7, respectively). In particular, 211 
voltage-induced cell death assays have been carried out using PC-3 cells seeded on simple metal 212 
substrate that is a representative working electrode among those used for bioelectrical stimulation 213 
therapies. Currently, there is a considerable amount of materials (e.g. carbon, platinum, gold, 214 
titanium, stainless steel and indium tin oxide, among others) that successfully work as potential 215 
biomedical electrodes [36]. Among all them, due to its inertness, electrochemical stability and 216 
corrosion resistance, the most employed is platinum. Nevertheless, it is limited by its poor 217 
mechanical stability and the expensiveness of this metal. Herein, we have chosen stainless steel (AISI 218 
316) because for short-duration pulsatile electrical stimulation protocols based on the application of 219 
low intensities, there is no risk of decomposition of the electrode and steel is more resistant to 220 
mechanical failures. 221 
The response of PC-3 cells seeded on stainless steel pins to electrical stimulation was studied by 222 
varying separately the following operating conditions: the voltage, the number of pulses applied, 223 
and the duration of such pulses (Figure 1). Negative voltages typically result in an enhancement of 224 
reduction reactions, while positive voltages cause an increase of oxidation reactions and higher ion 225 
release from metallic surfaces, the main drawback in this case being the dissolution of iron from the 226 
stainless steel substrate [36,37]. Furthermore, there is an increase of reactive oxygen species (ROS) 227 
products on the electrode surface which can cause oxidative cellular stress. Initially, the response of 228 
cells cultured for 24 h onto the steel pins towards voltages of –1.0, 0.3, 0.5 and 1.0 V, which were 229 
applied during 1 min, was examined.  230 
Figure 1a shows the implication of such voltage treatments in terms of current density, which 231 
ranges from –0.5 (–1.0 V) to 23 A/cm2 (1.0 V), and accumulated charge, which varies from –17 (–1.0 232 
V) to 58 mC (1.0 V). Thus, the effects of those voltages were evaluated 24 h after their application, 233 
determining the cell viability. Figure 1b shows that the cell viability underwent a significant 234 
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reduction when voltages of 1.0 and –1.0 V were employed, diminishing in both cases to 60%. 235 
Amazingly, the electro-regulated release of CUR from PEDOT-NPs/CUR started at –0.5 V with 10%, 236 
and grew to 30% and 38% when the reductive voltage decreased to –1.0 and –1.2 V, respectively [12]. 237 
Similarly, the maximum effectivity for the release of CUR from PCL/PEDOT-NPs/CUR was achieved 238 
when a voltage of 1.0 V was applied [16], that as shown in Figure 1 affects severely the cell viability. 239 
These observations indicate that the on-demand drug release by electrical stimulation should consist 240 
on a balance between the effectivity in the release kinetics and the cell health. 241 
 242 
Figure 1. (a) Relation between the applied voltage and both the current density (bars) and the 243 
accumulated charge (circles). (b) Cell viability and (c) radical scavenging activity after apply a 244 
voltage pulse during 1 min. (d) Cell viability after apply 1 and 3 pulses of 1.0 V during 1 min (Control 245 
and OCP refers to non-stimulated and open circuit potential, respectively). In all cases, cells were 246 
cultured on stainless pins (0.5  1.0 cm2) within a tissue well-plate (20·103 cells/well) for 24 h. After 247 
this time, pins were used as working electrodes and pulses were applied at the desired voltage for 1 248 
min. Finally, the pins were placed in a new tissue well-plate for 24 h before to conduct the MTT and 249 
ABTS assays. Each data point corresponds to the average of three samples and the error bars refer to 250 
the respective standard deviation.  251 
The radical scavenging activity of cells seeded onto the stainless steel was halved along with 252 
cell viability when a voltage of 1.0 V was applied (Figure 1a-c). It is well-known that oxygen 253 
molecules can generate hazardous products called ROS during reactions occurring on the 254 
intracellular space. Hence, cells have an antioxidant defense system to keep free radical formation 255 
controlled. However, in our case this defense was not minored after the use of 1.0 V during 1 min 256 
since its decrease was proportional to the decrease in cell viability. Therefore, this observation let us 257 
to conclude that cells might be damaged following another underlying mechanism or the 258 
combination of various. We hypothesize that this effect may be due to the associated 259 
nano-toxicology of the stimulated stainless steel where the cells are seeded. 260 
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The influence of the number of pulses was evaluated by determining the cell viability after 261 
apply 1 or 3 pulses of 1.0 V during 1 min (Figure 1d). As it can be seen, significant differences were 262 
observed between non-stimulated and electro-stimulated cells, the viability being 30% lower for 263 
the latter than for the former. However, no statistical difference was appreciated between 1 and 3 264 
potential pulses, suggesting that the damage caused by the accumulated charge and the current 265 
density occurs after the first pulse. Overall, findings reported in Figure 1 suggest that reductive and 266 
moderately oxidative voltages do not cause important alterations on cells viability and metabolism 267 
while, in opposition, application of potential of a voltage as high as 1.0 V is clearly pernicious. This 268 
point is crucial for the utilization of electrically stimulated drug delivery devices since it would not 269 
be easy to differentiate whether the harmfulness is caused by the applied voltage or by the own 270 
released drug. 271 
 272 
Figure 2. SEM images of (a) PEDOT-NPs and (b) PEDOT-NPs/CUR (Scale bar: 200 nm). Effective 273 
diameter histograms derived from SEM measurements and average values are also displayed.(c) 274 
Cyclic voltammograms of the carbon anode coated with 10 uL PEDOT-NPs and PEDOT-NPs/CUR 275 
(10 mg/mL). 276 
Taken results displayed in Figure 1 into consideration, PC-3 cells were incubated onto 277 
PEDOT-NPs and PEDOT-NPs/CUR. The diameter of the PEDOT-NPs and PEDOT-NPs/CUR, was 278 
99  21 and 158  29 nm, respectively, as determined by SEM (Figure 2). Electroactivity and 279 
electrostability of the PEDOT-NPs and PEDOT-NPs/CUR was evaluated by means of cyclic 280 
voltammograms. The voltammogram area increases when the electrodes are coated with 281 
Materials 2019, 12, x FOR PEER REVIEW 8 of 15 
 
PEDOT-NPs and PEDOT-NPs/CUR (Figure 2c), the latter showing the oxidation peak of the drug at 282 
0.3 V.  283 
These materials present high electroestability because after 10 consecutive cycles its 284 
electroactivity loss was lower than 15%. Electrical stimulation experiments were undertaken using 285 
voltages of 0.5 V and –0.5 V. The cytoxicity of PEDOT-NPs and PEDOT-NPs/CUR for PC-3 cells, 286 
expressed as half-maximal cytotoxic concentration (CC50) is around 500 mg/mL and 100 µg/mL, 287 
respectively, as reported in previous work [12].  288 
 289 
Figure 3. (a) TEM images if cell incubated without and with PEDOT-NPs (25 mg/mL) for 24 h (top 290 
and bottom, respectively). Read arrows indicate the PEDOT-NPs. N, E and PM refer to nucleus, 291 
endosome and plasma membrane. (b) Relative cell viability of PC-3 cells cultured on stainless steel 292 
pins (control), PEDOT-NPs and PEDOT-NPs/CUR non-stimulated and after one pulse of 30 s of 0.5 V 293 
or –0.5 V. The data points correspond to the average of three samples and the error bars refer to the 294 
respective standard deviation. Greek letters on the columns indicate a significant difference (p < 0.05) 295 
when 1 way ANOVA and Turkey’s multiple comparison tests have been applied. (c) SEM 296 
micrographs (scale bar: 100 µm) of cells growth onto the non-stimulated control and 297 
electro-stimulated (one pulse of 30 s of 0.5 V) control, PEDOT-NPs and PEDOT-NPs/CUR. 298 
Magnifications (scale bar: 100 nm) represent the PEDOT-NPs and PEDOT-NPs/CUR that were not 299 
endocytosed and remained on the cell surface.  300 
TEM micrographs of non-treated cells and cell incubated with PEDOT-NPs are compared in 301 
Figure 3a. As it can be seen, cells are able to endocite PEDOT NPs. Accordingly, herein a 302 
concentration below CC50 values (e.g. 50 µg/mL) was considered to examine the cell viability after 303 
electrical stimulation. Figure 3b compares the viabilities of cells cultured on PEDOT-NPs, 304 
PEDOT-NPs/CUR and steel (control) after electrostimulation (i.e. the voltage was applied after 24 h 305 
of cell culture and the viabilities were determined 24 h after applying the potential) with those of 306 
non-stimulated control samples (i.e. viabilities determined after 48 h of cell culture). Results reveal 307 
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that concentrations of PEDOT-NPs/CUR, which were not harmful in absence of electrical stimuli, 308 
caused a drastic reduction in terms of cell viability after electro-stimulation. More specifically, the 309 
cell viability was halved after apply a voltage of 0.5 or –0.5 V. In contrast, the cell viability was just 310 
reduced to 75% when steel and PEDOT-NPs were electrically stimulated. These observations 311 
indicate that, as it expected, CUR was delivered by electrical stimulation but also that the drug 312 
preserves the anticancer activity.  313 
 314 
Figure 4. SEM micrographs of electrospun (a) PCL and (b) PCL/PEDOT-NPs/CUR fibrous mats 315 
before electrical stimulation. Effective diameter histograms derived from SEM measurements and 316 
average values are also displayed. The inset in (b) shows a few PEDOT-NPs (red circles) in the 317 
surface of the fibers. (c) Typical I-V curves obtained using different applied voltages. (d) 318 
Representative SEM micrograph of a PCL/PEDOT-NPs/CUR fibrous mat after apply a voltage of 0.5 319 
V for 1 min.  320 
Cell morphologies were characterized by SEM (Figure 3c). A monolayer of cells was observed 321 
on the stainless steel pins used as control, independently of the presence of electrical stimulus. 322 
Similarly, cells seeded on PEDOT-NPs presented a spread appearance as well, even after the 323 
application of the voltage. Instead, electrically stimulated PEDOT-NPs/CUR underwent a drastic 324 
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reduction of both the area covered by cells and the density of contacts between cells. These 325 
observations are fully consistent with cell viabilities, indicating that, despite its anti-cancer activity 326 
and other beneficious therapeutic properties, CUR is not a completely safe drug and exhibits some 327 
cytotoxicity.  328 
After this, the impact of the electric field on PC-3 and MCF7 human cancer cells seeded onto 329 
PCL/PEDOT-NPs/CUR fibrous mats has been evaluated and observations have been correlated with 330 
the amount of delivered CUR. For this purpose, PCL (blank) and PCL/PEDOT-NPs/CUR (target) 331 
microfibers were prepared. The contact angles of PCL and PCL/PEDOT-NPs/CUR were reported to 332 
be 128º  4º and 112º  7º, respectively [16]. Figures 4a and 4b display representative SEM 333 
micrographs of PCL and PCL/PEDOT-NPs/CUR fibers, respectively. Electrospun PCL mats are 334 
formed by a random distribution of homogeneous microfibers with a diameter of 3.7±0.8 µm and a 335 
smooth surface. Instead, PCL/PEDOT-NPs/CUR microfibers, which present a diameter of 3.9±0.7 336 
µm, were proved to exhibit PEDOT-NPs individually segregated. These were mainly distributed 337 
inside the polyester matrix, even though a few PEDOT-NPs were also located at the surface of the 338 
polyester matrix, as is illustrated in Figure 4b (inset). The conductivity of the different mats was 339 
evaluated using a four proves machine and by comparing the slopes of the current-voltage (I-V) 340 
curves (Figure 4c). The conductivity decreases as follows PCL/PEDOT-NPs ̴ PCL/PEDOT-NPs/CUR > 341 
PCL/CUR > PCL. These results indicate that the incorporation of PEDOT-NPs, as suspected, 342 
increased the conductivity of the material making it ideal for promoting an electrostimulated drug 343 
delivery.  344 
The release mechanism from PCL/PEDOT-NPs/CUR is based on the events caused in 345 
PEDOT-NPs by electrical stimulation (i.e. conformational movements, electrostatic repulsions and 346 
compositional variations through the entrance of hydrated anions), which induce changes in their 347 
volume [16]. Thus, the mechanical energy associated to such volume increment is used to alter the 348 
structure of PCL microfibers, the movement of PCL molecules generating macroscopic CUR release. 349 
In addition, electrical stimulation promotes the massive appearance of PEDOT-NPs at the surface of 350 
the microfibers. This is illustrated in the SEM micrograph displayed in Figure 4d, which shows the 351 
huge amount of PEDOT NPs after apply a voltage of 0.5 V for 1 min, confirming that the main part of 352 
the PEDOT-NPs were initially located inside the PCL matrix. 353 
Electrical stimuli, which consisted on 1 pulses of 0.5 V for 1 min each, were applied to bare 354 
stainless steel pins (control) and steel pins coated with electrospun PCL or PCL/PEDOT-NPs/CUR 355 
fibrous mats. Figure 5a compares cell viabilities for the different substrates. As is shown, the viability 356 
of cells seeded onto PCL is higher for the PC-3 line than for the MCF7 line, indicating a dependence 357 
on the characteristics and morphology of cells, which directly affect to their affinity towards PCL 358 
fibers. On the other hand, CUR released from PCL/PEDOT-NPs/CUR by electrical stimulation 359 
influences considerably the survival of cancer cells. As it was expected, differences in the viability of 360 
cells submitted or not to electrical stimuli were not significant for the control and blank substrates, 361 
independently of the cell line. Thus, the applied potential was not high enough to damage the cells 362 
(Figure 1b) and no anticancer drug to induce cell death was loaded into these substrates. In contrast, 363 
significant differences were encountered in the case of the cells seeded onto PCL/PEDOT-NPs/CUR 364 
matrices, reflecting that the regulated CUR release diminished the viability of cancer cells. It is well 365 
known that CUR could induce apoptosis in most, but not all, cancer cell lines by inducing changes in 366 
cell membrane potential [38]. According to the literature, MCF7 tumor cells are very sensitive to the 367 
presence of CUR [39]. For the case of PC-3 cells, it was reported that CUR affects the proliferation 368 
(anti-proliferative property) but the induced apoptosis is lower than for MCF7 cells [40]. These 369 
results show that when the electrical stimulation is carried out in a controlled manner, so that the 370 
operational parameters do not damage the cells, the effects produced by the released drug 371 
correspond to those desired.  372 
Cell spreading is mainly governed by traction forces exerted by cytoskeletal fibers. F-actin, 373 
which is the predominant component of the cytoskeletal machinery, was visualized together with 374 
the cell nuclei by confocal microscopy. Figure 5b compares representative images of PC-3 and MCF7 375 
cells cultured on steel pins and both PCL and PCL/PEDOT-NPs/CUR fibrous mats that were not 376 
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perturbed during 48 h (non-stimulated) and that were electro-stimulated by applying 1 pulse of 0.5 377 
V for 1 min just after 24 h of culture and, subsequently, remained unperturbed until reach 48 h. As it 378 
was expected, colonization and spreading of these substrates are consistent will viabilities displayed 379 
in Figure 5a. Thus, the lowest cell spreading, which corresponds to the electrically stimulated 380 
PCL/PEDOT-NPs/CUR, has been associated to the activity of the released drug. In contrast, no 381 
significant difference is apparently observed between cells colonizing non-stimulated and 382 
stimulated control and blank substrates. 383 
 384 
Figure 5. (a) Relative cell viability of PC-3 and MCF7 without and with electrical stimuli (1 pulse of 385 
0.5 V for 1 min). (b) Morphology of cells cultured onto stainless steel pins and both PCL and 386 
PCL/PEDOT-NPs/CUR fibrous mats without and with electrical stimuli (1 pulse of 0.5 V for 1 min). 387 
Confocal microscopy micrographs recorded after 48 h of cell culture (non-stimuli) or 24 h after 388 
applying the electrical stimuli, which in turn was done 24 h after starting the cell culture. Cells were 389 
stained for the nucleus in blue (Hoechst) and F-actin in green (Phalloidin Atto 488). Magnified 390 
images are also displayed for MCF7 cells cultured with electrical stimuli. In all cases scale bar = 100 391 
μm. Each data point in (a) correspond to the average of three samples and the error bars refer to the 392 
respective standard deviation. Greek letter on the column indicates a significant difference (p < 0.05) 393 
when 1 way ANOVA and Turkey’s multiple comparison tests have been applied. 394 
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In order to provide more insights about the changes induced by electrical stimulation on PC-3 395 
and MCF7 cells, both the cell area and cell circularity were analysed with the ImageJ software 396 
(Figure 6). These analyses were conducted using representative confocal microscopy micrographs of 397 
cells spread onto PCL and PCL/PEDOT-NPs/CUR fibrous mats. Regarding to cell area measures, 398 
results indicate that the major observable difference between the non-stimulated and the 399 
electro-stimulated substrates corresponds to the decrease in the cell area for the 400 
PCL/PEDOT-NPs/CUR matrices. In contrast, this change is not detected for cells cultured onto PCL 401 
scaffolds (Figure 6a). Considering the results reported in Figures 1, 3b and 4a, the reduction in the 402 
area of cells in contact with electro-stimulated PCL/PEDOT-NPs/CUR microfibers with respect 403 
non-stimulated ones have mainly attributed to the anticancer activity of the drug and/or the simple 404 
presence of CUR-loaded fibers rather than to the operating conditions employed for the electrical 405 
stimulation. 406 
 407 
Figure 6. Quantification of (a) cell area and (b) cell circularity of MCF7 and PC-3 cells cultured onto 408 
both PCL and PCL/PEDOT-NPs/CUR fibrous mats without and with electrical stimuli (1 pulse of 0.5 409 
V for 1 min). Each data point correspond to the average of three samples and the error bars refer to 410 
the respective standard deviation.  411 
On the other hand, the influence of electrical stimulation on cell circularity is unmeaning, the 412 
main features displayed in Figure 5b being due to the influence exerted by the fibrous substrates on 413 
cell lines with different stiffness. Thus, although MCF7 epithelial-like cells usually present high 414 
circularity with values ranging from 0.7-0.9 [41], cells cultured onto fibrous mats become elongated, 415 
showing circularities of 0.3. This loss of roundness is consistent with the high deformability of 416 
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MCF7 cells, which has been recently reported to exhibit significant shear-induced heterogeneous 417 
deformation [42]. More specifically, biophysical analyses of fluid shear stress in a microfluidic 418 
device that mimicked the hemodynamic conditions of blood stream, showed a quick significant 419 
reduction in circularity for MCF7 cells. On the other hand, the response of PC-3 cells to the fibrous 420 
substrates was less pronounced than that of MCF7 cells. Thus, the cell circularity of PC3 was 0.5, 421 
suggesting a lower deformability than MCF7 cells.  422 
4. Conclusions 423 
In summary, we have compared the behavior of CUR-loaded PEDOT-NPs and 424 
PLC/PEDOT-NPs microfibers without and with electro-stimulation to preliminarily evaluate the 425 
effect of these drug delivery systems. Results show that these devices can be used as a reservoir of 426 
CUR, which can be released upon electrical pulse stimulation. We also demonstrated that the 427 
response of prostate and breast tumor cells (PC-3 and MCF7, respectively) exposed to such 428 
CUR-loaded electroactive platforms depends on the operating conditions used for 429 
electro-stimulation (i.e. magnitude of the voltage, number of pulses, time of each pulse, etc.). For 430 
PEDOT-NPs the response of the cells was appropriated when pulses of 30 s of 0.5 V or –0.5 V were 431 
applied. In the case of PCL/PEDOT-NPs, which is based on an electro-actuation mechanism, the 432 
duration of the 0.5 V pulses must be increased to 1 min. Thus, controlled electrical stimulation 433 
restricting the operational parameters does not damage the cells during the CUR release process. 434 
However, the utilization of higher potentials to accelerate the drug release kinetics is harmful, 435 
causing a drastic reduction in the cell viability. Taken together, the results indicate that the studied 436 
platforms can be electro-stimulated without significant alteration of the cells health. 437 
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